Restricted accessReview articleFirst published online 2026
The Impact of Hemoglobin Concentration on Prognosis in Patients With Diabetic Foot: A Systematic Review and Meta-Analysis of Risk Factors for Adverse Outcomes and Clinical Management
Diabetic foot (DF) complications, including diabetic foot ulcers (DFUs), lead to significant morbidity, disability, and economic burden. Hemoglobin (Hb) levels may influence the prognosis of DF patients, but their relationship with adverse clinical outcomes remains unclear. This systematic review and meta-analysis aimed to assess the association between hemoglobin concentration and the risk of adverse outcomes in diabetic foot patients, including amputation and mortality.
Methods
We followed PRISMA guidelines to conduct a systematic literature review. A meta-analysis was performed on observational studies assessing the impact of hemoglobin levels on amputation, mortality, and ulcer incidence. A random-effects model was applied, and risk bias was evaluated using the Newcastle-Ottawa Scale.
Results
A total of 22 observational studies involving 10,984 patients were included. Our meta-analysis revealed that lower hemoglobin levels were significantly associated with a higher risk of amputation (OR = 0.97, 95% CI: 0.94-0.99, P < .001), and lower hemoglobin concentrations were found in amputation cases compared to non-amputation cases (SMD = −0.14, 95% CI: −0.24 to −0.04, P < .01). However, no significant association was found between hemoglobin levels and mortality (OR = 0.99, 95% CI: 0.33-2.89, P > .05). Sensitivity and publication bias analyses indicated robust results.
Conclusion
Lower hemoglobin levels were associated with higher odds of amputation in patients with diabetic foot. However, pooled effects were small and heterogeneity was substantial across studies; therefore, hemoglobin likely functions primarily as a marker of overall disease burden and perioperative risk rather than a proven modifiable target. Prospective interventional studies are needed to determine whether correcting anemia improves limb outcomes and survival.
ColeJBFlorezJC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16(7):377-390. doi:10.1038/s41581-020-0278-5.
2.
SaeediPPetersohnISalpeaP, et al.Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843.
3.
BandoHAbeYSakamotoK, et al.Profile of blood glucose in diabetic patient suffered from diabetic foot osteomyelitis with effective low carbohydrate diet. Diabetes Research - Open Journal. 2020;6:10-16. doi:10.17140/DROJ-6-144.
4.
KhanTMAsgharOSadiqaA, et al.Predisposing Factors of Diabetic Foot Amputation Among the Diabetic Patients in a Tertiary Care Hospital. Indian J Public Health Res Dev. 2022;14(1):370-375.
5.
The Lancet DiabetesE. Moving forward with research and care for diabetic foot disease. Lancet Diabetes Endocrinol. 2016;4(9):717. doi:10.1016/s2213-8587(16)30190-5.
6.
BoultonAJVileikyteLRagnarson-TennvallGApelqvistJ. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719-1724. doi:10.1016/s0140-6736(05)67698-2.
7.
WangDOuyangJZhouPYanJShuLXuX. A novel low-cost wireless footwear system for monitoring diabetic foot patients. IEEE Trans Biomed Circuits Syst. 2021;15(1):43-54. doi:10.1109/tbcas.2020.3043538.
8.
DasSKRoyPSinghP, et al.Diabetic foot ulcer identification: a review. Diagnostics. 2023;13(12):1998. doi:10.3390/diagnostics13121998.
9.
ThomasMTsalamandrisCMacIsaacRJerumsG. Anaemia in diabetes: an emerging complication of microvascular disease. Curr Diabetes Rev. 2005;1(1):107-126. doi:10.2174/1573399052952587.
10.
ShamseerLMoherDClarkeM, et al.Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Br Med J. 2015;350:g7647. doi:10.1136/bmj.g7647.
11.
SheaBJReevesBCWellsG, et al.Amstar 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. Br Med J. 2017;358:j4008. doi:10.1136/bmj.j4008.
12.
StroupDFBerlinJAMortonSC, et al.Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-2012. doi:10.1001/jama.283.15.2008.
13.
StangA. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603-605. doi:10.1007/s10654-010-9491-z.
14.
AlmohammadiAAAlnashriMMAbdulrahmanTHRAlsamiriSMAlkhatiebMT. Pattern and type of amputation and mortality rate associated with diabetic foot in Jeddah, Saudi Arabia: a retrospective cohort study. Ann Med Surg. 2022;73:103174. doi:10.1016/j.amsu.2021.103174.
15.
BagheriSEKhalagiKNasli-EsfahaniE, et al.Risk factors for diabetic foot ulcer in diabetic patients at the Tehran diabetes clinic: a case-control study. J Diabetes Metab Disord. 2025;24(1):70. doi:10.1007/s40200-025-01582-z.
16.
BrookesJDLJayaJSTranH, et al.Broad-ranging nutritional deficiencies predict amputation in diabetic foot ulcers. Int J Low Extrem Wounds. 2020;19(1):27-33. doi:10.1177/1534734619876779.
17.
CaoJWangJZhangSGaoG. Association between anemia and diabetic lower extremity ulcers among US outpatients in the National Health and Nutrition Examination survey: a retrospective cross-sectional study. Front Endocrinol. 2024;15:1387218. doi:10.3389/fendo.2024.1387218.
18.
ChenYZhuangJYangCZ. Development of a major amputation prediction model and nomogram in patients with diabetic foot. Postgrad Med J. 2024;100(1190):908-916. doi:10.1093/postmj/qgae087.
19.
ChoiJJLeeJYLeeKCJoYY. Preanesthetic mortality prediction in diabetics undergoing major lower limb amputation at a tertiary referral hospital: implications of preoperative echocardiographic and laboratory values. J Crit Care. 2015;30(5):1021-1024. doi:10.1016/j.jcrc.2015.04.122.
20.
CostaRHRCardosoNAProcópioRJNavarroTPDardikAde Loiola CisnerosL. Diabetic foot ulcer carries high amputation and mortality rates, particularly in the presence of advanced age, peripheral artery disease and anemia. Diabetes Metabol Syndr. 2017;11(Suppl 2):S583-s587. doi:10.1016/j.dsx.2017.04.008.
21.
DemirkolDAktaşŞÖzcanTTannierXSelçukcan ErolÇ. Analysis of risk factors for amputation in patients with diabetic foot ulcers: a cohort study from a tertiary center. Acta Orthop Traumatol Turcica. 2022;56(5):333-339. doi:10.5152/j.aott.2022.22052.
22.
GolinkoMSMargolisDJTalAHoffstadOBoultonAJMBremH. Preliminary development of a diabetic foot ulcer database from a wound electronic medical record: a tool to decrease limb amputations. Wound Repair Regen. 2009;17(5):657-665. doi:10.1111/j.1524-475X.2009.00527.x.
23.
GongHRenYLiZ, et al.Clinical characteristics and risk factors of lower extremity amputation in the diabetic inpatients with foot ulcers. Front Endocrinol. 2023;14:1144806. doi:10.3389/fendo.2023.1144806.
24.
GuoZYueCQianQHeHMoZ. Factors associated with lower-extremity amputation in patients with diabetic foot ulcers in a Chinese tertiary care hospital. Int Wound J. 2019;16(6):1304-1313. doi:10.1111/iwj.13190.
25.
JeonBJChoiHJKangJSTakMSParkES. Comparison of five systems of classification of diabetic foot ulcers and predictive factors for amputation. Int Wound J. 2017;14(3):537-545. doi:10.1111/iwj.12642.
26.
JiangYFWangXMXiaL, et al.A cohort study of diabetic patients and diabetic foot ulceration patients in China. Wound Repair Regen. 2015;23(2):222-230. doi:10.1111/wrr.12263.
27.
JiangMYGanFGanMS, et al.Predicting the risk of diabetic foot ulcers from diabetics with dysmetabolism: a retrospective clinical trial. Front Endocrinol. 2022;13:929864. doi:10.3389/fendo.2022.929864.
28.
LiXXiaoTWangY, et al.Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital. Diabetes Res Clin Pract. 2011;93(1):26-30. doi:10.1016/j.diabres.2011.03.014.
29.
LuQWangJWeiXWangGXuY. Risk factors for major amputation in diabetic foot ulcer patients. Diabetes Metab Syndr Obes. 2021;14:2019-2027. doi:10.2147/dmso.S307815.
30.
MusaIRAhmedMONSabirEI, et al.Factors associated with amputation among patients with diabetic foot ulcers in a Saudi population. BMC Res Notes. 2018;11(1):260. doi:10.1186/s13104-018-3372-z.
31.
NamgoongSJungSHanSKJeongSHDhongESKimWK. Risk factors for major amputation in hospitalised diabetic foot patients. Int Wound J. 2016;13:13-19. doi:10.1111/iwj.12526.
32.
RodriguesBTVangavetiVNMalabuUH. Prevalence and risk factors for diabetic lower limb amputation: a clinic-based case control study. J Diabetes Res. 2016;2016:5941957. doi:10.1155/2016/5941957.
33.
YangBZhaXWDingYL. Risk factors associated with amputation for patients with diabetic foot ulcers: a retrospective study. Diabetes Metab Syndr Obes. 2024;17:4201-4209.
34.
YaoYChenLQianY. Age characteristics of patients with type 2 diabetic foot ulcers and predictive risk factors for lower limb amputation: a population-based retrospective study. J Diabetes Res. 2024;2024:2380337. doi:10.1155/jdr/2380337.
35.
ShareefAMAhmedaniMYWarisN. Strong association of anemia in people with diabetic foot ulcers (DFUs): study from a specialist foot care center. Pakistan J Med Sci. 2019;35(5):1216-1220. doi:10.12669/pjms.35.5.1421.
36.
KumarRSinghSKAgrawalNK, et al.The prevalence of anemia in hospitalized patients with Diabetic Foot Ulcer (DFU) and the relationship between the severity of anemia and the severity of DFU. Cureus. 2023;15(7):e41922. doi:10.7759/cureus.41922.
37.
YammineKAkikiSAssiCHayekF. Anemia prevalence among patients with diabetic foot ulcers necessitating surgery on admission: a preliminary, retrospective comparative study. Wounds. 2022;34(8):216-219. doi:10.25270/wnds/21073.
38.
WangAXuZMuYJiL. Clinical characteristics and medical costs in patients with diabetic amputation and nondiabetic patients with nonacute amputation in central urban hospitals in China. Int J Low Extrem Wounds. 2014;13(1):17-21. doi:10.1177/1534734614521235.
39.
ZhangSSTangZYFangPQianHJXuLNingG. Nutritional status deteriorates as the severity of diabetic foot ulcers increases and independently associates with prognosis. Exp Ther Med. 2013;5(1):215-222. doi:10.3892/etm.2012.780.
40.
JiangYRanXJiaL, et al.Epidemiology of type 2 diabetic foot problems and predictive factors for amputation in China. Int J Low Extrem Wounds. 2015;14(1):19-27. doi:10.1177/1534734614564867.
41.
HoepersATMenezesMMFrödeTS. Systematic review of anaemia and inflammatory markers in chronic obstructive pulmonary disease. Clin Exp Pharmacol Physiol. 2015;42(3):231-239. doi:10.1111/1440-1681.12357.
42.
ChuanFZhangMYaoYTianWHeXZhouB. Anemia in patients with diabetic foot ulcer: prevalence, clinical characteristics, and outcome. Int J Low Extrem Wounds. 2016;15(3):220-226. doi:10.1177/1534734616660224.
43.
ChaparroCMSuchdevPS. Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries. Ann N Y Acad Sci. 2019;1450(1):15-31. doi:10.1111/nyas.14092.
44.
GrodsinskyCNiblerJGBrushBE. Complications of peptic ulcer disease in geriatric patients. J Am Geriatr Soc. 1973;21(9):398-404. doi:10.1111/j.1532-5415.1973.tb01698.x.
45.
AlsayeghFWaheediMBayoudTAl HubailAAl-RefaeiFSharmaP. Anemia in diabetes: experience of a single treatment center in Kuwait. Prim Care Diabetes. 2017;11(4):383-388. doi:10.1016/j.pcd.2017.04.002.
46.
DesormaisIAboyansVBuraA, et al.Anemia, an independent predictive factor for amputation and mortality in patients hospitalized for peripheral artery disease. Eur J Vasc Endovasc Surg. 2014;48(2):202-207. doi:10.1016/j.ejvs.2014.04.005.
47.
AzizZLinWKNatherAHuakCY. Predictive factors for lower extremity amputations in diabetic foot infections. Diabet Foot Ankle. 2011;2:7463. doi:10.3402/dfa.v2i0.7463.
48.
ZhangXLiQZhouXXuYShuZDengH. Risk factors for amputation in diabetic foot ulcers: a retrospective analysis. Int Wound J. 2024;21(4):e14832. doi:10.1111/iwj.14832.
